Abstract
957P Interim report of Notable-HCC: A phase Ib study of neoadjuvant PD-1 with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma (HCC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have